MENU
+Compare
FOLD
Stock ticker: NASDAQ
AS OF
May 23 closing price
Price
$6.22
Change
-$0.04 (-0.64%)
Capitalization
1.92B

FOLD Amicus Therapeutics Forecast, Technical & Fundamental Analysis

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases... Show more

Industry: #Biotechnology
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for FOLD with price predictions
May 23, 2025

FOLD's RSI Oscillator climbs out of oversold territory

The RSI Indicator for FOLD moved out of oversold territory on May 15, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 20, 2025. You may want to consider a long position or call options on FOLD as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FOLD just turned positive on May 16, 2025. Looking at past instances where FOLD's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FOLD advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where FOLD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOLD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FOLD entered a downward trend on May 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.891) is normal, around the industry mean (16.345). P/E Ratio (0.000) is within average values for comparable stocks, (59.117). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.182). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (3.499) is also within normal values, averaging (279.466).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. FOLD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOLD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

FOLD is expected to report earnings to fall 128.33% to 0 cents per share on July 31

Amicus Therapeutics FOLD Stock Earnings Reports
Q2'25
Est.
$-0.01
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.10
Q2'24
Est.
$-0.05
The last earnings report on May 01 showed earnings per share of 2 cents, beating the estimate of -1 cents. With 2.82M shares outstanding, the current market capitalization sits at 1.92B.
A.I. Advisor
published General Information

General Information

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PICRX44.360.18
+0.41%
Putnam International Capital Opp R
SIGIX12.88-0.02
-0.16%
Seafarer Overseas Gr and Income Instl
VMFVX366.11-0.66
-0.18%
Vanguard S&P Mid-Cap 400 Value Idx I
JVSCX13.23-0.08
-0.60%
Janus Henderson Small-Mid Cap Value C
JUEPX23.95-0.15
-0.62%
JPMorgan US Equity R3

FOLD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.64%
VCYT - FOLD
43%
Loosely correlated
-1.63%
ROIV - FOLD
42%
Loosely correlated
-0.64%
ATXS - FOLD
41%
Loosely correlated
N/A
KRYS - FOLD
40%
Loosely correlated
-1.29%
IMVT - FOLD
39%
Loosely correlated
+0.35%
More